Future veterinary diagnostics

Journal of Exotic Pet Medicine

Volumn 19, Issue 2, 2010, Pages 117-132

  Dahlhausen, Bob ^a  

^a Veterinary Molecular Diagnostic Inc   (United States)

Author keywords

Biosensor; Infectious disease; Metabolomics; Microarray; Polymerase chain reaction; Veterinary diagnostics

Indexed keywords

EID: 77956798975     PISSN: 15575063     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jepm.2010.05.006     Document Type: Article

References (94)

1. Niesters H.G. Clinical virology in real time. J Clin Virol 2002, 25:S3-S12.
2. Giljohann D.A., Mirkin C.A. Drivers of biodiagnostic development. Nature 2009, 462:461-464.
3. Olsen G., Speer B. Laboratory reporting accuracy of polymerase chain reaction testing for psittacine beak and feather disease virus. J Avian Med Surg 2009, 23:194-198.
4. Kleppe K., Ohtsuka E., Kleppe R., et al. Repair replications of short synthetic DNA's as catalyzed by DNA polymerases. J Mol Biol 1971, 56:341-361.
5. Kary B. Mullis Nobel Lecture on December 8, 1993 The Nobel Prize Foundation. http://nobelprize.org/nobel_prizes/chemistry/laureates/1993/mullis-lecture.html.
6. Lanciotti R.S., Kerst A.J., Nasci R.S., et al. Rapid West Nile virus. J Clin Microbiol 2000, 38:4066-4074.
7. Tyagi S., Kramer F.R. Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol 1996, 14:303-308.
8. Wittwer C.T., Herrmann M.G., Moss A.A., et al. The Light Cycler: a microvolume multisamplefluorimeter with rapid temperature control. Biotechniques 1997, 2:130-131.
9. Mori Y., Notomi T. Loop-mediated isothermal amplification (LAMP): a rapid, accurate, and cost-effective diagnostic method for infectious diseases. J Infect Chemother 2009, 15:62-69.
10. Mhlanga M.M., Malmberg L. Using molecular beacons to detect single-nucleotide polymorphisms with real-time PCR. Methods 2001, 25:463-471.
11. van Belkum A., Niesters H.G. Nucleic acid amplification and related techniques in microbiological diagnostics and epidemiology. Cell Mol Biol 1995, 41:615-623.
12. Malek L., Sooknanan R., Compton J. Nucleic acid sequence based amplification (NASBA). J Virol Methods 1994, 47:141-151.
13. Collins R.A., Ko L.S., So K.L., et al. Detection of highly pathogenic and low pathogenic avian influenza subtype H5 (Eurasian lineage) using NASBA. J Virol Meth 2002, 103:213-225.
14. Collins R.A., Ko L.S., Fung K.Y., et al. A method to detect major serotypes of foot-and-mouth disease virus. Biochem Biophys Res Commun 2002, 297:267-274.
15. Majtan T., Bukovska G., Timko J. DNA microarrays-techniques and applications in microbial systems. Folia Microbiol 2004, 49:635-664.
16. Jayasena S.D. Aptamers: an emerging class of molecules that rival antibodies in diagnostics. Clin Chem 1999, 45:1628-1650.
17. Heller M.J. DNA Microarray technology: devices, systems, and applications. Annu Rev Biomed Eng 2002, 4:129-153.
18. Douglas R. Challenges and opportunities for pathogen detection using DNA microarrays. Crit Rev Microb 2005, 31:91-99.
19. Tombelli S., Minunni M., Mascini M. Analytical application of aptamers. Biosens Bioelectron 2005, 20:2424-2434.
20. Mascini M., Tombelli S. Biosensors for biomarkers in medical diagnostics. Biomarkers 2008, 13:637-657.
21. Troesch A., Nguyen H., Miyada C.G., et al. Mycobacterium species identification and rifampin resistance testing with high density DNA probe arrays. J Clin Microb 1999, 37:49-55.
22. Tobler N.E., Pfunder M., Herzog K., et al. Rapid detection and species identification of Mycobacterium spp. using real-time PCR and DNA microarray. J Microbiol Meth 2005, 66:116-124.
23. Leland D.S., Ginocchio C.C. Role of cell culture for virus detection in the age of technology. Clin Microbiol Rev 2007, 1:49-78.
24. Ojha S., Kostrzynska M. Examination of animal and zoonotic pathogens using microarrays. Vet Res 2008, 39:4.
25. Liu Y.C., Huang G.S., Wu M.C., et al. Detection of foot and mouth disease and porcine reproductive and respiratory syndrome viral genes using microarray chip. Vet Res Comm 2006, 30:191-204.
26. Dawson E.D., Moore C., Smagala J.A., et al. MChip: a tool for influenza surveillance. Anal Chem 2006, 78:7610-7615.
27. Dawson E.D., Moore C.L., Dankbar D.M., et al. Identification of A/H5N1 influenza viruses using a single gene diagnostic microarray. Anal Chem 2007, 79:378-384.
28. Wang D., Coscoy L., Zylberberg M., et al. Microarray-based detection and genotyping of viral pathogens. Proc Natl Acad Sci U S A 2002, 99:15687-15692.
29. Sengupta S., Onodera K., Lai A., et al. Molecular detection and identification of influenza viruses by oligonucleotide microarray hybridization. J Clin Microbiol 2003, 41:4542-4550.
30. Rota P.A., Oberste M.S., Monroe S.S., et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003, 300:1394-1399.
31. Kistler A.L., Gancz A., Clubb S., et al. Recovery of divergent avian bornaviruses from cases of proventricular dilatation disease: identification of a candidate etiologic agent. J Virol 2008, 5:1-15.
32. Greisen K., Loeffelholz M., Purohit A., et al. PCR primers and probes for the 16SrRNA gene of most species of pathogenic bacteria, including bacteria found in cerebrospinal fluid. J Clin Microbiol 1994, 32:335-351.
33. Wang J. Survey and summary: from DNA biosensors to gene chips. Nucleic Acids Res 2000, 28:3011-3016.
34. Diehn M., Relman D.A. Comparing functional genomic datasets: lessons from DNA microarray analyses of host pathogen interactions. Curr Opin Microbiol 2001, 4:95-101.
35. Soini H., Musser J.M. Molecular diagnosis of mycobacteria. Clin Chem 2001, 47:809-814.
36. Meltzer P.S. Spotting the target: microarrays for disease gene discovery. Curr Opin Genet Dev 2001, 11:258-263.
37. Cojocaru G.S., Rechavi G., Kaminski N. The use of microarrays in medicine. J Isr Med Assoc 2001, 3:292-296.
38. Wildsmith S.E., Elcock F.J. Microarrays under the microscope. Mol Pathol 2001, 54:8-16.
39. Wade C.M., Giulotto E., Sigurdsson S., et al. Genome sequence, comparative analysis, and population genetics of the domestic horse. Science 2009, 326:865-867.
40. Levy S., Sutton G., Ng P.C., et al. The diploid genome sequence of an individual human. PLoS Biol 2007, 5:e254.
41. Lindblad-Toh K., Wade C.M., Mikkelsen T.S., et al. Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 2005, 438:803-819.
42. Pontius J.U., Mullikin J.C., Smith D.R., et al. Initial sequence and comparative analysis of the cat genome. Genome Res 2007, 17:1675-1689.
43. O'Brien S.J., Johnson W., Driscoll C., et al. State of cat genomics. Trends Genet 2008, 24:268-279.
44. Venkatasubbarao S. Microarrays-status and prospects. Trends Biotechnol 2004, 22:630-637.
45. Kulesh D.A., Clive D.R., Zarlenga D.S., et al. Identification of interferon-modulated proliferation- related cDNA sequences. Proc Natl Acad Sci U S A 1987, 84:8453-8457.
46. Schena M., Shalon D., Davis R.W., et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995, 270:467-470.
47. Iannuzzi L., Di Berardino D. Tools of the trade: diagnostics and research in domestic animal cytogenetics. J Appl Genet 2008, 49:357-366.
48. Adomas A., Heller G., Olson A., et al. Comparative analysis of transcript abundance in Pinus sylvestris after challenge with a saprotrophic, pathogenic or mutualistic fungus. Tree Physiol 2008, 28:885-897.
49. Holzwarth J.A., Middleton R.P., Roberts M., et al. The development of a high-density canine microarray. J Hered 2005, 96:817-820.
50. Hacia J.G., Fan J.B., Ryder O., et al. Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays. Nat Genet 1999, 22:164-167.
51. The National Scrapie Surveillance Plan United States Department of Agriculture, Veterinary Services. http://www.aphis.usda.gov/vs/nahss/sheep/national_scrapie_surveillance_plan_08192008.pdf.
52. Pollack J.R., Perou C.M., Alizadeh A.A., et al. Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 1999, 23:41-46.
53. Moran G., Stokes C., Thewes S., et al. Comparative genomics using Candida albicans DNA microarrays reveals absence and divergence of virulence-associated genes in Candida dubliniensis. Microbiology 2004, 150:3363-3382.
54. Shaffer L.G., Bejjani B.A. Medical applications of array CGH and the transformation of clinical cytogenetics. Cytogenet Genome Res 2006, 115:303-309.
55. Breen M., Modiano J.F. Evolutionarily conserved cytogenetic changes in hematological malignancies of dogs and humans-man and his best friend share more than companionship. Chromosome Res 2008, 16:145-154.
56. Avery A. Molecular diagnostics of hematologic malignancies. Top Companion Anim Med 2009, 24:144-150.
57. MacBeath G., Schreiber S.L. Printing proteins as microarrays for high-throughput function determination. Science 2000, 289:1760-1763.
58. Angenendt P. Progress in protein and antibody microarray technology. Drug Discov Today 2005, 10:503-511.
59. Bertone P., Snyder M. Advances in functional protein microarray technology. J FEBS 2005, 272:5400-5411.
60. Uttamchandani M., Walsh D.P., Yao S.Q., et al. Small molecule microarrays: recent advances and applications. Curr Opin Chem Biol 2005, 9:4-13.
61. Uttamchandani M., Yao S.Q. Peptide microarrays: next generation biochips for detection, diagnostics and high-throughput screening. Curr Pharm Des 2008, 14:2428-2438.
62. Maynard J.A., Myhre R., Roy B. Microarrays in infection and immunity. Curr Opin Chem Biol 2007, 1:306-315.
63. MacBeath G. Protein microarrays and proteomics. Nat Genet 2002, 32. 526-332.
64. Templin M.F., Stoll D., Schwenk J.M., et al. Protein microarrays: promising tools for proteomic research. Proteomics 2003, 3:2155-2166.
65. Hartmann M., Roeraade J., Stoll D., et al. Protein microarrays for diagnostic assays. Anal Bioanal Chem 2009, 393:1407-1416.
66. Cai H.Y., Lu L., Muckle C.A., et al. Development of a novel protein microarray method for serotyping Salmonella enterica strains. J Clin Microbiol 2005, 43:3427-3430.
67. Anjum M.F., Tucker J.D., Sprigings K.A., et al. Use of miniaturized protein arrays for Escherichia coli O serotyping. Clin Vaccine Immunol 2006, 13:561-567.
68. Thirumalapura N.R., Morton R.J., Ramachandran A., et al. Lipopolysaccharide microarrays for the detection of antibodies. J Immunol Methods 2005, 298:73-81.
69. Thirumalapura N.R., Ramachandran A., Morton R.J., et al. Bacterial cell microarrays for the detection and characterization of antibodies against surface antigens. J Immunol Methods 2006, 309:48-54.
70. Deregt D., Furukawa-Stoffer T.L., Tokaryk K.L., et al. A microsphere immunoassay for detection of antibodies to avian influenza virus. J Virol Methods 2006, 137:88-94.
71. Zhu H., Hu S., Jona G., et al. Severe acute respiratory syndrome diagnostics using a coronavirus protein microarray. Proc Natl Acad Sci U S A 2006, 103:4011-4016.
72. Cho W.C. Contribution of oncoproteomics to cancer biomarker discovery. Mol Cancer 2007, 6:25.
73. Johnson C.J., Zhukovsky N., Cass A.E., et al. Proteomics, nanotechnology and molecular diagnostics. Proteomics 2008, 8:715-730.
74. Kalbas M., Lueking A., Kowald A., et al. New analytical tools for studying autoimmune diseases. Curr Pharm Des 2006, 12:3735-3742.
75. Atkinson A.J., Colburn W.A., DeGruttola V.G., et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001, 69:89-95.
76. Boswood A., Murphy A. The effect of heart disease, heart failure and diuresis on selected laboratory and electrocardiographic parameters in dogs. J Vet Cardiol 2006, 8:1-9.
77. Farabaugh A.E., Freeman L.M., Rush J.E., et al. Lymphocyte subpopulations and hematologic variables in dogs with congestive heart failure. J Vet Intern Med 2004, 18:505-509.
78. Morrow D.A., de Lemos J.A. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation 2007, 115:949-952.
79. Boswood A. Biomarkers in cardiovascular disease: beyond natriuretic peptides. J Vet Card 2009, 11:S23-S32.
80. Luppa P.B., Sokoll L.J., Chan D.W. Immunosensors-principles and applications to clinical chemistry. Clin Chim Acta 2001, 314:1-26.
81. Rackley C.E. New clinical markers predictive of cardiovascular disease: the role of inflammatory mediators. Cardiol Rev 2004, 12:151-157.
82. Soper S.A., Brown K., Ellington A.D., et al. Point-of-care biosensor systems for cancer diagnostics/prognostics. Biosens Bioelectron 2006, 21:1932-1942.
83. Wilson M.S., Nie W. Multiplex measurement of seven tumor markers using an electrochemical protein chip. Anal Chem 2006, 78:6476-6483.
84. Wu J., Yan F., Tang J., et al. A disposable multianalyte electrochemical immunosensor array for automated simultaneous determination of tumor markers. Clin Chem 2007, 53:1495-1502.
85. Wu J., Fu Z., Yan F., et al. Biomedical and clinical applications of immunoassays and immunosensors for tumor markers. Trends Anal Chem 2007, 26:679-688.
86. Lin Y.Y., Wang J., Liu G., et al. A nanoparticle label/immunocromatographic electrochemical biosensor for rapid and sensitive detection of prostate-specific antigen. Biosens Bioelectron 2008, 23:1659-1665.
87. Stevens R.C., Soelber S.D., Near S., et al. Detection of cortisol in saliva with a flow-filtered portable surface plasmon resonance biosensor system. Anal Chem 2008, 80:6747-6751.
88. Palchetti I., Mascini M. Nucleic acid biosensors for environmental pollution monitoring. Analyst 2008, 133:846-854.
89. Jones O.A., Cheung V.L. An introduction to metabolomics and its potential application in veterinary science. Am Assoc Lab Anim Sci 2007, 57:436-442.
90. Whitfield P.D., Noble P.J., Major H., et al. Metabolomics as a diagnostic tool for hepatology: validation in a naturally occurring canine model. Metabolomics 2005, 1:215-225.
91. Griffin J.L., Walker L.A., Troke J., et al. The initial pathogenesis of cadmium induced renal toxicity. FEBS Lett 2000, 478:147-150.
92. Viant M.R., Pincetich C.A., Walton J.H., et al. Utilizing in vivo nuclear magnetic resonance spectroscopy to study sublethal stress in aquatic organisms. Mar Environ Res 2002, 54:553-557.
93. Pears M.R., Cooper J.D., Mitchison H.M., et al. High resolution 1H NMR based metabolomics indicates a neurotransmitter cycling deficit in cerebral tissue from a mouse model of batten disease. J Biol Chem 2005, 280:42508-42514.
94. Bergeron M.G. Molecular testing in laboratory medicine. Clinical Chemistry, 1998-2001 2001, 217-218. AACC Press, Washington, DC. D.E. Bruns (Ed.).